Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients.
about
Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implicationsPulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
P2860
Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nebulized liposomal amikacin f ...... n in cystic fibrosis patients.
@en
type
label
Nebulized liposomal amikacin f ...... n in cystic fibrosis patients.
@en
prefLabel
Nebulized liposomal amikacin f ...... n in cystic fibrosis patients.
@en
P2093
P2860
P1476
Nebulized liposomal amikacin f ...... n in cystic fibrosis patients.
@en
P2093
Jacqueline Denise Wetzel
John P Clancy
Zarmina Ehsan
P2860
P304
P356
10.1517/13543784.2014.895322
P407
P577
2014-03-05T00:00:00Z